Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

被引:0
|
作者
Nathan J. Lanning
Joshua P. Castle
Simar J. Singh
Andre N. Leon
Elizabeth A. Tovar
Amandeep Sanghera
Jeffrey P. MacKeigan
Fabian V. Filipp
Carrie R. Graveel
机构
[1] California State University,Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology
[2] Van Andel Research Institute,College of Human Medicine
[3] University of California Merced,undefined
[4] Michigan State University,undefined
来源
关键词
Triple-negative breast cancer; Metabolism; Rate-limiting enzymes; Receptor tyrosine kinase; Tyrosine kinase inhibitor; Metabolic inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Single-cell RNA-seq reveals the metabolic status of immune cells response to immunotherapy in triple-negative breast cancer
    Liu, Pei-Wen
    Lin, Jun
    Hou, Rui
    Cai, Zhe
    Gong, Yue
    He, Ping-An
    Yang, Jialiang
    COMPUTERS IN BIOLOGY AND MEDICINE, 2024, 169
  • [42] Functional Proteomic Profiling of Triple-Negative Breast Cancer
    Gromova, Irina
    Espinoza, Jaime A.
    Grauslund, Morten
    Santoni-Rugiu, Eric
    Talman, Maj-Lis Moller
    van Oostrum, Jan
    Moreira, Jose M. A.
    CELLS, 2021, 10 (10)
  • [43] Metabolic characterization of triple negative breast cancer
    Cao, Maria D.
    Lamichhane, Santosh
    Lundgren, Steinar
    Bofin, Anna
    Fjosne, Hans
    Giskeodegard, Guro F.
    Bathen, Tone F.
    BMC CANCER, 2014, 14
  • [44] Metabolic characterization of triple negative breast cancer
    Maria D Cao
    Santosh Lamichhane
    Steinar Lundgren
    Anna Bofin
    Hans Fjøsne
    Guro F Giskeødegård
    Tone F Bathen
    BMC Cancer, 14
  • [45] Chromosome arm aneuploidies as genetic vulnerabilities of triple-negative breast cancer
    Dandage, Rohan
    Schwartz, Michael
    Karam, Lynn
    Pacis, Alain
    Hart, Traver
    Bourque, Guillaume
    Park, Morag
    Kuzmin, Elena
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer (vol 42, 143, 2023)
    de Heer, E. C.
    Zois, C. E.
    Bridges, E.
    van der Vegt, B.
    Sheldon, H.
    Veldman, W. A.
    Zwager, M. C.
    van der Sluis, T.
    Haider, S.
    Morita, T.
    Baba, O.
    Schroder, C. P.
    de Jong, S.
    Harris, A. L.
    Jalving, M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [47] Metabolic Profile of Triple-negative Breast Cancer in African-American Women Reveals Potential Biomarkers of Aggressive Disease
    Kanaan, Yasmine M.
    Sampey, Brante P.
    Beyene, Desta
    Esnakula, Ashwini K.
    Naab, Tammey J.
    Ricks-Santi, Luisel J.
    Dasi, Sylvia
    Day, Agnes
    Blackman, Kwesi W.
    Frederick, Wayne
    Copeland, Robert L., Sr.
    Gabrielson, Edward
    Dewitty, Robert L., Jr.
    CANCER GENOMICS & PROTEOMICS, 2014, 11 (06) : 279 - 294
  • [48] Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer
    Evans, Kurt W.
    Yuca, Erkan
    Scott, Stephen S.
    Zhao, Ming
    Arango, Natalia Paez
    Pico, Christian X. Cruz
    Saridogan, Turcin
    Shariati, Maryam
    Class, Caleb A.
    Bristow, Christopher A.
    Vellano, Christopher P.
    Zheng, Xiaofeng
    Gonzalez-Angulo, Ana Maria
    Su, Xiaoping
    Tapia, Coya
    Chen, Ken
    Akcakanat, Argun
    Lim, Bora
    Tripathy, Debu
    Yap, Timothy A.
    Di Francesco, Maria Emilia
    Draetta, Giulio F.
    Jones, Philip
    Heffernan, Timothy P.
    Marszalek, Joseph R.
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2021, 81 (21) : 5572 - 5581
  • [49] SLC1A4 is associated with metabolic reprogramming in triple-negative breast cancer
    Park, Soo Young
    Kim, Da Sol
    Kim, Hayeon
    Song, Min Ji
    Ryu, Han Suk
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Macropinocytosis mediates metabolic resistance to loss of glutamine transport in triple-negative breast cancer
    Wahi, Kanu
    Freidman, Natasha
    Wang, Qian
    Guan, Yi Fang
    Holst, Jeff
    CANCER RESEARCH, 2024, 84 (03)